Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study
Regional Anesthesia & Pain Medicine · 2025-05 · 50 (5) · 421-428
DOI: 10.1136/rapm-2023-105035 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Regional Anesthesia & Pain Medicine, online erschienen am 18.03.2024. Verfasst von Antoine Elyn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chronic Pain Center, University Hospital of Toulouse, Toulouse, France elyn.a@chu-toulouse.fr. Hauptthemen laut MEDLINE: Ketamine, Chronic Pain, Analgesics, Opioid, Opioid-Related Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Long-term opioid use is associated with pharmacological tolerance, a risk of misuse and hyperalgesia in patients with chronic pain (CP). Tapering is challenging in this context, particularly with comorbid opioid-use disorder (OUD). The antihyperalgesic effect of ketamine, through N-methyl-D-aspartate (NMDA) antagonism, could be useful. We aimed to describe the changes in the dose of opioids consumed over 1 year after a 5-day hospitalisation with ketamine infusion for CP patients with OUD.
Methods
We performed a historical cohort study using a medical chart from 1 January 2014 to 31 December 2019. Patients were long-term opioid users with OUD and CP, followed by the Pain Center of the University Hospital of Toulouse, for which outpatient progressive tapering failed. Ketamine was administered at a low dose to initiate tapering during a 5-day hospitalisation.
Results
59 patients were included, with 64% of them female and a mean age of 48±10 years old. The most frequent CP aetiologies were back pain (53%) and fibromyalgia (17%). The baseline opioid daily dose was 207 mg (±128) morphine milligram equivalent (MME). It was lowered to 92±72 mg MME at discharge (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chronic Pain Center, University Hospital of Toulouse, Toulouse, France elyn.a@chu-toulouse.fr.
- General and Family Medicine University Department, University of Toulouse III - Paul Sabatier, Toulouse, France.
- RECaP F-CRIN - Réseau national de Recherche en Épidémiologie Clinique et en Santé Publique, Inserm, Toulouse, France.
- Clinical Pharmacology, University Hospital of Toulouse, Toulouse, France.
- INSERM UMR1295, Pharmaco-épidémiologie, University of Toulouse III - Paul Sabatier, Toulouse, France.
- University of Medicine, University of Toulouse III - Paul Sabatier, Toulouse, France.
ORCID-Profile: Antoine Elyn
Zitieren
APA
Elyn, A., Roussin, A., Lestrade, C., Franchitto, N., Jullian, B., & Cantagrel, N. (2025). Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study. Regional Anesthesia & Pain Medicine, 50(5), 421-428. https://doi.org/10.1136/rapm-2023-105035
Vancouver
Elyn A, Roussin A, Lestrade C, Franchitto N, Jullian B, Cantagrel N. Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study. Regional Anesthesia & Pain Medicine. 2025;50(5):421-428. doi:10.1136/rapm-2023-105035
BibTeX
@article{Elyn2025,
author = {Elyn, Antoine and Roussin, Anne and Lestrade, Cécile and Franchitto, Nicolas and Jullian, Bénédicte and Cantagrel, Nathalie},
title = {Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study},
journal = {Regional Anesthesia & Pain Medicine},
year = {2025},
volume = {50},
number = {5},
pages = {421--428},
doi = {10.1136/rapm-2023-105035}
}
EUVIMED